Subscribe To Our Free Newsletter |
Indoco Remedies gains after receiving USFDA nod for type 2 diabetes drug
Indoco Remedies added 2.68% to Rs 317.55 after the company has received tentative approval from the US Food and Drug administration (USFDA) for its abbreviated new drug application (ANDA) for canagliflozin and metformin tablets.